P

Inventor

RUEDIGER EDWARD H

CA52 patents
⚠️ This page may combine multiple inventors who share the name “RUEDIGER EDWARD H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

38 patents
US7659270B2Feb 9, 2010

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO72 citations98
US6713487B2Mar 30, 2004

Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same

BRISTOL MYERS SQUIBB CO78 citations97
US7759495B2Jul 20, 2010

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO41 citations96
US7745636B2Jun 29, 2010

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO53 citations94
US7741347B2Jun 22, 2010

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO52 citations94
US7704992B2Apr 27, 2010

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO58 citations94
US8642025B2Feb 4, 2014

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO12 citations92
US7348337B2Mar 25, 2008

Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides

BRISTOL MYERS SQUIBB CO37 citations92
US9688695B2Jun 27, 2017

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO11 citations90
US9227961B2Jan 5, 2016

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO6 citations84
US8846023B2Sep 30, 2014

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO7 citations84
US7449476B2Nov 11, 2008

Tetrahydrocarboline antiviral agents

BRISTOL MYERS SQUIBB CO11 citations84
US7396830B2Jul 8, 2008

Piperazine amidines as antiviral agents

BRISTOL MYERS SQUIBB CO16 citations84
US10822343B2Nov 3, 2020

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO4 citations83
US10428077B2Oct 1, 2019

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO8 citations83
US10047103B2Aug 14, 2018

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO11 citations83
US7102003B2Sep 5, 2006

Pyrrolotriazine compounds

BRISTOL MYERS SQUIBB CO11 citations82
US5434154AJul 18, 1995

Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkylpiperazines

BRISTOL MYERS SQUIBB CO19 citations82
US7064203B2Jun 20, 2006

Di-substituted pyrrolotriazine compounds

BRISTOL MYERS SQUIBB CO9 citations74
US10238638B2Mar 26, 2019

Benzothiazole and benzothiophene compounds

BRISTOL MYERS SQUIBB CO4 citations73
US9018390B2Apr 28, 2015

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO4 citations73
US7067525B2Jun 27, 2006

Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same

BRISTOL MYERS SQUIBB CO8 citations73
US6979691B2Dec 27, 2005

Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same

BRISTOL MYERS SQUIBB CO6 citations73
US5300506AApr 5, 1994

Indolylalkyl derivatives of pyrimidinylpiperazine for treating vascular headache

BRISTOL MYERS SQUIBB CO11 citations73
US5618816AApr 8, 1997

Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines

BRISTOL MYERS SQUIBB CO13 citations72
US9862730B2Jan 9, 2018

Imidazothiadiazole derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO5 citations70
US7501419B2Mar 10, 2009

4-Squarylpiperazine derivatives as antiviral agents

BRISTOL MYERS SQUIBB CO5 citations63
US7915283B2Mar 29, 2011

Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides

BRISTOL MYERS SQUIBB CO3 citations61
US6677450B2Jan 13, 2004

Topoisomerase inhibitors

BRISTOL MYERS SQUIBB CO3 citations61
US6653290B2Nov 25, 2003

Tumor proliferation inhibitors

BRISTOL MYERS SQUIBB CO2 citations61
US12084452B2Sep 10, 2024

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO0 citations60
US5521188AMay 28, 1996

Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines

BRISTOL MYERS SQUIBB CO5 citations60
US5382592AJan 17, 1995

Antimigraine cyclobutenedione derivatives of tryptamines

BRISTOL MYERS SQUIBB CO2 citations60
US9758487B2Sep 12, 2017

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO0 citations52
US9505752B2Nov 29, 2016

Piperidine amide derivatives as HIV attachment inhibitors

BRISTOL MYERS SQUIBB CO0 citations52
US7138377B2Nov 21, 2006

Topoisomerase inhibitors

BRISTOL MYERS SQUIBB CO0 citations51
US6686385B2Feb 3, 2004

Anhydro sugar derivatives of indolocarbazoles

BRISTOL MYERS SQUIBB CO1 citations49
US6610727B2Aug 26, 2003

Anhydro sugar derivatives of indolocarbazoles

BRISTOL MYERS SQUIBB CO1 citations49

BACHAND CAROL

6 patents

UNIV MONTREAL

2 patents

LAVOIE RICO

1 patent

BRISTOL MYERS CO

1 patent

FABRE KRAMER PHARMACEUTICALS I

1 patent

VIIV HEALTHCARE UK (NO 5) LTD

1 patent

Showing the top 50 of 52 patents by PatentIndex Score.